Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Boehringer furthers inflammatory expansion with €407M biobucks bet on Immunitas asset
Nia JulianMay 18, 2026
Facebook0 Twitter Pinterest0 0 Likes
Previous

InduPro Closes $77 Million Series B Financing and Doses First Patient in Phase 1 Study of Lead Oncology Program IDP-001

Nia JulianAugust 12, 2026
Next

Biogen to buy Apellis Pharmaceuticals for $5.6 billion in rare disease push

Nia JulianMarch 31, 2026

© 2020 Solasta Ventures. All Rights Reserved.